Insulin resistance, acanthosis nigricans, and hypertriglyceridemia.
Eberting
Cheryl Lee D
CL
Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-1908, USA.
Javor
Edward
E
Gorden
Phillip
P
Turner
Maria L
ML
Cowen
Edward W
EW
D051103:1-Acylglycerol-3-Phosphate O-Acyltransferase; D000052:Acanthosis Nigricans / Q000209:etiology*; D000217:Acyltransferases / Q000172:deficiency* / Q000235:genetics; D000273:Adipose Tissue / Q000378:metabolism / Q000473:pathology; D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000235:genetics*; D005234:Fatty Liver / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006628:Hirsutism / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy / Q000209:etiology; D015228:Hypertriglyceridemia / Q000188:drug therapy / Q000235:genetics*; D007333:Insulin Resistance; D020738:Leptin / Q000172:deficiency / Q000627:therapeutic use; D008060:Lipodystrophy / Q000150:complications / Q000151:congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D008599:Menstruation Disturbances / Q000209:etiology
D020738:Leptin; D000217:Acyltransferases; D051103:1-Acylglycerol-3-Phosphate O-Acyltransferase